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ABSTRACT: 
A  simple,  precise,  rapid, and accurate RP-HPLC  method  has been  developed  to determine  esomeprazole  magnesium  trihydrate using  chromatographic  
separation isocratically on C18 column (5 μm, 150mm x 4.60mm) and acetonitrile: water (HPLC grade) in the ratio of 50:50 (v/v) as the mobile phase, at a 
flow rate of 1ml/min. Detection was carried out at 289 nm. The retention times was found to be 5.6, the method was linear in the concentration range of 10-
60μg/ml with R
2=0.997 respectively. The proposed method is successfully applied for the determination of drugs in commercial tablet preparation. The results 
of the analysis have been validated statistically and by recovery studies. 
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INTRODUCTION:  
Esomeprazole  magnesium  trihydrate  is  chemically  bis(5-
methoxy-2-[(S)  -[(4-  methoxy-3,  5-dimethyl-2-  pyridinyl) 
methyl]  sulfinyl]-1-  H-benzimidazole-1-yl)  magnesium 
trihydrate and it belongs to a class of proton pump inhibitor 
used in treatment of peptic ulcer disease
1,5. Nafisur Rahman 
et  al  developed  Spectrophotometric  determination  of 
esomeprazole  magnesium  in  commercial  tablets  using  5-
sulfosalicylic acid and n-bromo succinimide
2, M. C. Sharma 
et  al  estimated    esomeprazole  magnesium  trihydrate  in 
pharmaceutical formulations using indigo carmine reagent by 
UV-Vis  spectrophotometric  method
3    and  S.  Lakshmana 
Prabu  et  al  performed  simultaneous  estimation  of 
esomeprazole  and  domperidone  by  UV  spectrophotometric 
method
4.  But  there  is  no  simple  and  easy  method  for  the 
analysis of esomeprazole. Hence, it is necessary to develop a 
rapid,  accurate  and  validated  RP-HPLC  method  for  the 
determination  of  Esomeprazole  in  tablet  dosage  form.  The 
method proved to be simple model since it does not contain a 
buffer  system.  This  paper  describes  the  development  and 
validation of reliable, simple, robust, time and money saving 
reversed phase HPLC method, using PDA detection, for the 
estimation  of  Esomeprazole  in  tablet  dosage  forms.  The 
developed method validated according to ICH guidelines. 
EXPERIMENTATION: 
EQUIPMENT: 
Chromatographic separation was performed on Waters HPLC 
system  having  PDA  detector  and  Rheodyne  injector  with 
20µl loop volume. Waters Empower software was applied for 
data collecting and processing. 
REAGENTS AND CHEMICALS: 
Acetonitrile and water of HPLC grade were procured from 
Merck Ltd. API of Esomeprazole received as a gift sample 
from  Dr.Reddy’s.  The  commercial  sample  ESOZ-  40mg 
(Glenmark) is purchased from the local market. 
HPLC CONDITIONS: 
A  Thermo  scientific  C18  (25cm×4.6mm,  5µ)  column  was 
used as the stationary phase.  A mixture of Acetonitrile and 
water in the ratio of (50:50v/v) was used as a mobile phase. It 
was  filtered  through  0.45µ  membrane  filter  and  degassed. 
The mobile phase was pumped at 1 ml/min. The eluents were 
monitored  at  289nm.The  injection  volumes  of  sample  and 
standard were 20µl. 
STANDARD-PREPARATION: 
Standard  stock  solutions  were  prepared  by  dissolving 
separately 20mg of  the drug in 100 ml of diluents which was 
a mixture of acetonitrile and water in the ratio of 50:50 to get 
a concentration of 200 μg/ml. 2ml of stock  was diluted to 
10ml with the mobile phase to get concentration 40µg/ml. 
ASSAY OF FORMULATION:   
Twenty  tablets  were  weighed  and  finely  powdered.  A 
synthetic  mixture  was  prepared  by  taking  powdered 
equivalent to 40 mg of esomeprazole in 100 ml diluents and 
then sonicated for 10 min. different concentrations of solution 
were prepared by a serial dilution technique as per standard 
and  each  dilution  was  analyzed.  The  drug  was  initially 
dissolved in acetonitrile and sonicated for 10 minutes. The   
volume  was  made  up  to  50ml  with  mobile  phase.  The 
solution  was  filtered  using  0.2µm  membrane  filter.  The 
aliquot was then suitably diluted to get final concentrations of 
40 µg/ml of esomeprazole.  Then 20µl of these solutions was 
injected in to the column, recorded and chromatogram was 
shown in Fig.1. Concentrations of esomeprazole in the tablet 
formulation were calculated by comparing area of the sample 
with that of standard. The percentage assay of the drug was 
calculated and presented in Table 1. 
VALIDATION OF THE METHOD: 
ACCURACY: 
Recovery studies were carried out by applying the standard 
addition method. A known amount of standard esomeprazole 
corresponding to 50%, 100%, and 150% of the label claim 
was  added  to  pre  analyzed  sample  of  tablet  dosage  form 
separately. The recovery studies were carried out three times, 
at each level of recovery. The data’s of accuracy were shown 
in (Table 2) 
PRECISION: 
In the system precision studies, six replicate injections of the 
working  standard  solution  prepared  as  per  the  proposed 
method  and  chromatograms  were  recorded.  Standard 
deviation  and  relative  standard  deviation  for  the  area  was 
calculated and presented in (Table 3). 
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LINEARITY AND RANGE: 
The  developed  method  has  been  validated  as  per  ICH 
guidelines. Every 20μl of the working standard solution of 
esomeprazole in the concentration range of 10-60 µg/ml (Fig 
2)  injected  into  the  chromatographic  system.  The 
chromatograms  were  developed  and  the  peak  area  was 
determined  for  each  concentration  of  the  drug  solution. 
Calibration curves of esomeprazole were obtained by plotting 
the  peak  area  ratio  versus  the  applied  concentrations. 
Linearity data’s were shown in Table.4. 
RUGGEDNESS AND ROBUSTNESS: 
The ruggedness of the method was determined by carrying 
out the experiment on different instrument like Waters HPLC 
and Shimadzu HPLC by different operators using different 
columns  of  similar  type  like  Phenomenex  C18,Hypersil 
C18.Robustness  of  the  method  was  determined  by  making 
slight  changes  in  the  experimental  conditions  such  as  the 
composition of the mobile phase,  pH  of  the  mobile  phase,  
and    flow    rate    of    the    mobile  phase  and  the 
chromatographic characteristics were evaluated.  
 
TABLE 1: REPORT FOR ASSAY: 
S.No  Drug  Amount present (mg/tab)  Amount found* (mg/tab)  % label claim* 
1  esomeprazole  40  39.97  99.92% 
 
TABLE 2: RECOVERY STUDIES OF ESOMEPRAZOLE 
Concentration  Peak area 
 
Amount Added 
µg/Ml 
Amount Present 
µg/Ml 
% Recovery  Mean % 
Recovery 
50%  19249  20  19.94  99.83%  100.11% 
  19431  20  20.08  100.4%   
  19278  20  19.98  100.1%   
100%  38543  40  40.20  99.5%   
  38472  40  40.001  100%  99.81% 
  38490  40  40.019  99.95%   
150%  47460  60  59.73  100.4%   
  47696  60  59.94  100.1%  99.9% 
  48013  60  60.45  99.2%   
 
TABLE 3: DATA FOR PRECISION: 
Sampling  Area 
1  38642 
2  38548 
3  38472 
4  38562 
5  38693 
6  38428 
Mean  38557 
Standard Deviation  44.46 
%RSD  0.11% 
 
TABLE 4: DATA FOR LINEARITY: 
Concentrations 
(ug/ml) 
Area 
10  11307 
20  17982 
30  29160 
40  38480 
50  48100 
60  57722 
 
FIG 1. CHROMATOGRAM OF THE SAMPLE: 
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FIG 2: LINEARITY: 
 
 
RESULTS AND DISCUSSION: 
The proposed method was found to be simple and sensitive 
with  linearity  in  the  concentration  range  of  esomeprazole 
between 10-60µg/ml. System suitability parameter indicates 
high column efficiency from the large number of theoretical 
plates (>2000). The degree of asymmetry was also evaluated 
using the tailing factor result 0.42, which did not exceed the 
critical  value  (1.5)  indicating  acceptable  degree  of  peak 
asymmetry. The method was found to be accurate and precise 
as  indicated  by  results  of  recovery  studies  and  precision 
studies  %RSD  not  more  than  2%.  There  were  no  marked 
changes  in  the  chromatograms  which  confirmed  the 
ruggedness of the method. The standard deviation of % assay 
for sample was calculated for each parameter in robustness 
studies and relative standard deviation was found less than 
2%.  The  low  RSD  value  confirms  the  robustness  of  the 
method. 
CONCLUSION: 
The  developed  RP-HPLC  method  for  the  determination  of 
esomeprazole  can  be  used  for  routine  analysis  of  this 
component in tablet dosage form. 
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